Scientific Industries, Inc. (SCND)
| Market Cap | 7.04M -7.8% |
| Revenue (ttm) | 5.73M +23.4% |
| Net Income | -741.30K |
| EPS | -0.07 |
| Shares Out | 11.93M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,000 |
| Open | 0.5900 |
| Previous Close | 0.6000 |
| Day's Range | 0.5900 - 0.5900 |
| 52-Week Range | 0.3000 - 0.8832 |
| Beta | 0.18 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |
About Scientific Industries
Scientific Industries, Inc. engages in the design, manufacture, and marketing of standard benchtop laboratory equipment, weight and measurement, and bioprocessing products in the United States, Germany, and internationally. The company offers laboratory vortex mixers, shakers, and accessories; rotators and rockers accessories; disruptors and shakers accessories; as well as incubators under the Genie brand name. It also provides pharmacy, laboratory, industrial digital scales, moisture analyzers, mechanical and automated pill counters, force gau... [Read more]
Financial Performance
In 2025, Scientific Industries's revenue was $5.05 million, an increase of 5.35% compared to the previous year's $4.80 million. Losses were -$1.22 million, -81.07% less than in 2024.
Financial StatementsNews
Scientific Industries Quarterly report: Q2 2026
Scientific Industries has published its Q2 2026 quarterly earnings report on August 14, 2026.
Scientific Industries Quarterly report: Q1 2026
Scientific Industries has published its Q1 2026 quarterly earnings report on May 15, 2026.
Scientific Industries Annual report: Q4 2025
Scientific Industries has published its Q4 2025 annual report on March 31, 2026.
Scientific Industries Proxy statement: Proxy Filing
Scientific Industries filed a proxy statement on December 29, 2025, providing details for shareholder voting and corporate governance matters.
Scientific Industries Earnings Call Transcript: Q3 2025
Q3 2025 saw record revenue, driven by strong sales in bioprocessing and new AI-driven product features. The company completed the Genie division divestiture and is focused on expanding its DOTS and VIVID platforms, despite ongoing market caution and selective capital spending.
Scientific Industries Quarterly report: Q3 2025
Scientific Industries has published its Q3 2025 quarterly earnings report on November 20, 2025.
Scientific Industries Announces Third Quarter 2025 Results And Launch of VIVID's New AI-Powered Feature
TORBAL DIVISION SALES UP 15% YTD LAUNCH OF VIVID'S FIRST AI-POWERED FEATURE SECOND GENERATION VIVID-ONE LAUNCH SCHEDULED FOR Q1 CY26
Scientific Industries to Host Third Quarter Fiscal Year 2025 Financial Results Investor Call on November 20, 2025
BOHEMIA, N.Y., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Scientific Industries, Inc. (OTCQB: SCND), a developer of digitally simplified bioprocessing products and vision-based pill counters, announced it will...
Scientific Industries Transcript: Lytham Partners Fall 2025 Investor Conference
The company has transformed into a digital and AI-focused life science innovator, divesting legacy assets to invest in pharmacy automation and bioprocessing. With strong financials, a robust product roadmap, and major industry partnerships, it targets rapid growth and leadership in AI-enabled scientific tools.
Scientific Industries to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025
BOHEMIA, N.Y., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Scientific Industries, Inc. (OTCQB: SCND), a developer of digitally simplified bioprocessing products and vision-based pill counters, today announced ...
Scientific Industries Earnings Call Transcript: Q2 2025
Legacy Genie division sold, shifting focus to AI-driven life science and bioprocessing. Q2 revenue rose 66% sequentially but lagged year-over-year, with academic sales sharply down. R&D and commercial engagement remain strong despite industry headwinds.
Scientific Industries Quarterly report: Q2 2025
Scientific Industries has published its Q2 2025 quarterly earnings report on August 20, 2025.
Scientific Industries Reports Financial Results for Second Quarter of Fiscal Year 2025
TORBAL DIVISION SALES UP 11% SECURED $10 MILLION IN STRATEGIC DIVESTURE OF GENIE PRODUCT LINE VIVID AND BIOPROCESSING NEW PRODUCT AI ROADMAP ON TARGET
Scientific Industries to Host Second Quarter Fiscal Year 2025 Financial Results Investor Call on August 20, 2025
BOHEMIA, N.Y., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Scientific Industries, Inc. (OTCQB: SCND), a developer of digitally simplified bioprocessing products and vision-based pill counters, announced it will...
Scientific Industries Completes Strategic Refocus and Secures Proceeds of $10 million to Accelerate Growth of Two Data-Driven Business Platforms; Divests Genie® Division to OHAUS Corporation's affiliate Troemner, LLC
Realign priorities - AI-powered platforms to accelerate innovation and market leadership Driving transformation in pharmacy automation with VIVID's advanced solutions Advancing AI-powered biomanufactu...
Scientific Industries Registration statement: Registration Filing
Scientific Industries filed a registration statement on July 18, 2025, providing details about a securities offering with the SEC.
Scientific Industries Registration statement: Registration Filing
Scientific Industries filed a registration statement on July 14, 2025, providing details about a securities offering with the SEC.
Scientific Industries Registration statement: Registration Filing
Scientific Industries filed a registration statement on July 1, 2025, providing details about a securities offering with the SEC.
Scientific Industries Registration statement: Registration Filing
Scientific Industries filed a registration statement on July 1, 2025, providing details about a securities offering with the SEC.
Scientific Industries Transcript: Lytham Partners Spring 2025 Investor Conference
The company is advancing digital automation in life science labs, launching new AI-enabled products and expanding its bioprocessing platform to reduce experiment costs and increase data output. With a strong financial position and major industry validation, it targets rapid growth and break-even by 2027.
Scientific Industries to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
BOHEMIA, N.Y., May 27, 2025 (GLOBE NEWSWIRE) -- Scientific Industries, Inc. (OTCQB: SCND), a life sciences tool provider, and a developer of digitally simplified bioprocessing products, announced it w...
Scientific Industries Earnings Call Transcript: Q1 2025
Q1 2025 saw strong benchtop equipment sales and increased U.S. demand, but bioprocessing revenue declined due to funding delays and longer sales cycles. Despite macroeconomic headwinds, new financing, product launches, and a robust sales pipeline position the company for growth later in 2025.
Scientific Industries Earnings release: Q1 2025
Scientific Industries released its Q1 2025 earnings on May 14, 2025, summarizing the period's financial results.
Scientific Industries Quarterly report: Q1 2025
Scientific Industries has published its Q1 2025 quarterly earnings report on May 14, 2025.
Scientific Industries Reports Financial Results for First Quarter of Fiscal Year 2025
BENCHTOP LAB EQUIPMENT SALES UP 5% FIRST PEER-REVIEWED PUBLICATION ON COMPANY'S DOTS MPS BIOPROCESSING PLATFORM RECORD NUMBER OF BIOPROCESSING SALES OPPORTUNITIES Investor Call to be held Wednesday, M...